Simplexa Group A Strep Direct, Simplexa Group A Strep Positive Control Pack

Groups A, C And G Beta-hemolytic Streptococcus Nucleic Acid Amplification System

FOCUS DIAGNOSTICS, INC.

The following data is part of a premarket notification filed by Focus Diagnostics, Inc. with the FDA for Simplexa Group A Strep Direct, Simplexa Group A Strep Positive Control Pack.

Pre-market Notification Details

Device IDK143651
510k NumberK143651
Device Name:Simplexa Group A Strep Direct, Simplexa Group A Strep Positive Control Pack
ClassificationGroups A, C And G Beta-hemolytic Streptococcus Nucleic Acid Amplification System
Applicant FOCUS DIAGNOSTICS, INC. 11331 VALLEY VIEW ST Cypress,  CA  90630
ContactSharon Young
CorrespondentSharon Young
FOCUS DIAGNOSTICS, INC. 11331 VALLEY VIEW ST Cypress,  CA  90630
Product CodePGX  
CFR Regulation Number866.2680 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2014-12-23
Decision Date2015-03-18
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
20816101025576 K143651 000
20816101025569 K143651 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.